Patent Assignment
Reel/Frame 044760/0906
Merger
Recorded: 2017-11-14
Pages: 26
Assignor
SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
Executed: 2017-08-01
Assignee
ALFASIGMA S.P.A.
VIALE SARCA N. 223,, MILANO (MI),, ITALY
Covered Properties
(45)
Composition for Prevention and/or Treatment of Vascular Diseases, Comprising Propionyl L-Carnitine and Coenzyme Q10
Treating Chronic Uremic Patients Undergoing Periodical Dialysis
Ultrafine-L-Carnitine, Methods of Preparing the Same, Compositions Containing the Same, and Methods of Using the Same
Aminoderivatives of Biotin and Their Conjugates with Macrocyclic Chelating Agents
Anti-Human Tenascin Monoclonal Antibody
Method for Treating Intermittent Claudication Comprising the Administration of Propionyl L-Carnitine and a Concomitant Physical Training
Carnitines for Treating or Preventing Disorders Caused by Andropause
Biotin Diaminoderivatives and Their Conjugates with Macrocyclic Chelating Agents
Container for Vial of Radiopharmaceutical and Set for Its Infusion in a Patient or for Its Transfer Elsewhere
Synthesis of Deoxybiotinyl Hexamethylenediamine-Dota
Solid Compositions Suitable for Oral Administration Containing Non-Hygroscopic Salts of L-Carnitine and the Alkanoyl L-Carnitines with Taurine Chloride and Glycine Chloride
Use of L-Carnitine for the Treatment of Cardiovascular Diseases
Medicament for the Two-Step Perioperative Therapy of Solid Tumours
Use of Carnitines for the Prevention and/or Treatment of Disorders Caused by the Andropause
Anti-Human Tenascin Monoclonal Antibody
Vector for Efficient Selection and/or Maturation of an Antibody and Uses Thereof
Use of Acetyl L-Carnitine in Combination with Propionyl L-Carnitine and Sildenafil for the Treatment of Erectile Dysfunction
Aminoderivative of Biotin and Their Conjugates with Macrocyclic Chelating Agents
Anti-Human Tenascin Monoclonal Antibody
Dietary Supplement Energy-Providing to Skeletal Muscles
Container for Vial of Radiopharmaceutical and Set for Its Infusion in a Patient or for Its Transfer Elsewhere
Anti-Epcam Antibody and Uses Thereof
Use of Alkanoyl L-Carnitine for the Treatment of Erectile Dysfunction
A Method Useful for the Prevention of Type 2 Diabetes and Its Complications in Pre-Diabetic Patients with Insulin Resistance
Use of L-Carnitine for the Treatment of Cardiovascular Diesases
Combined use of L-carnitine, acetyle L-carnitine and propionyl L-carnitine for the treatment of oligoasthenoteratospermia
Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections
Oxidized Avidin with High Residency Time in the Treated Tissues
Acetyl L-Carnitine for Prevention of Painful Peripheral Neuropathy in Patients with Type 2 Diabetes
Composition Useful for the Prevention or Reduction of the Progression of Prostate Cancer
New Thio Derivatives Bearing Lactams as Potent Hdac Inhibitors and Their Uses as Medicaments
Acetyl L-Carnitine for the Preparation of a Medicament for the Prevention of Painful Peripheral Neuropathy in Patients with Type 2 Diabetes
Composition Useful for the Prevention or Reduction of the Progression of Prostate Cancer
Composition Useful for the Treatment of Lipid Metabolism Disorders
Oxidated Derivatives of Triazolylpurines Useful as Ligands of the Adenosine A2A Receptor and Their Use as Medicaments
COMBINATION COMPOSITION, COMPRISING AS ACTIVE INGREDIENTS L-CARNITlNE OR PROPIONYL L-CARNITlNE, FOR THE PREVENTION OR TREATMENT OF CHRONIC VENOUS INSUFFICIENCY
Combined use of l-carnitine, acetyl l-carnitine and propionyl l-carnitine for the treatment of oligoasthenoteratospermia
Application:
10/510,450 →
Publication:
US US20050107470A1
Pharmaceutical Composition of Oxidised Avidin Suitable for Inhalation
Vector for Efficient Selection and/or Maturation of an Antibody and Uses Thereof
Application:
14/998,264 →
Composition Useful as a Dietary Supplement
Compounds Useful for Increasing Neurogenesis in Neural Tissue
Application:
15/159,321 →
Publication:
US US20160310458A1
Solid Formulations Containing Omega-3 and Resveratrol
Application:
15/316,152 →
Publication:
US US20170112791A1
Homogeneous Formulation Comprising Omega-3 Polyunsatured Fatty Acid and Resveratrol for Oral Administration
Vector for Efficient Selection and/or Maturation of an Antibody and Uses Thereof
Patent:
45,968 →
Application:
13/831,258 →
Long-Term Treatment of Symptomatic Heart Failure
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 7, 2012
From: TECNOGEN S.P.A.
To: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE, S.P.A.
Reel/Frame 029258/0849 →
Assignment of Assignor's Interest
Nov 7, 2012
From: TECNOGEN S.P.A.
To: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE, S.P.A.
Reel/Frame 029259/0195 →
Change of Address
Oct 15, 2019
From: ALFASIGMA S.P.A.
To: ALFASIGMA S.P.A.
Reel/Frame 050727/0652 →